NCT02920216View on ClinicalTrials.gov

Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 6, 2016

Primary Completion Date

August 10, 2017

Study Completion Date

September 6, 2017

Conditions
Head and Neck Cancer
Interventions
DRUG

indocyanine green

intravenous injection of Indocyanine Green (0,25mg/kg) before surgery.

Trial Locations (1)

54519

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Institut de Cancérologie de Lorraine

OTHER

NCT02920216 - Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area | Biotech Hunter | Biotech Hunter